2016
DOI: 10.5761/atcs.ra.16-00032
|View full text |Cite
|
Sign up to set email alerts
|

Efficacy and Safety of Transcatheter Aortic Valve Implantation for Bicuspid Aortic Valves: A Systematic Review and Meta-Analysis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

4
7
1
1

Year Published

2018
2018
2021
2021

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 12 publications
(13 citation statements)
references
References 34 publications
4
7
1
1
Order By: Relevance
“…Among the reasons that led to consider BAV patients at high risk for TAVI procedures are some characteristics of the aortic annulus such as a more elliptic shape than in patients with TAV. This different conformation has been suggested as the cause for the higher rate of paravalvular regurgitation in BAV patients [10,14,33,34]. With an AR > 1 at all phases and for all BAV types, but significantly more in early systolic phase for valves type 1, our study demonstrated that the annulus of BAV patients has an elliptic shape.…”
Section: Discussionsupporting
confidence: 47%
“…Among the reasons that led to consider BAV patients at high risk for TAVI procedures are some characteristics of the aortic annulus such as a more elliptic shape than in patients with TAV. This different conformation has been suggested as the cause for the higher rate of paravalvular regurgitation in BAV patients [10,14,33,34]. With an AR > 1 at all phases and for all BAV types, but significantly more in early systolic phase for valves type 1, our study demonstrated that the annulus of BAV patients has an elliptic shape.…”
Section: Discussionsupporting
confidence: 47%
“…Secondary endpoints such as 30-day permanent pacemaker (PPM) implantation, moderate-to-severe prosthetic valve regurgitation, acute kidney injury and composite clinical endpoints 30-day safety, and device success defined in the Valve Academic Research Consortium 2 (VARC-2) were evaluated to detect early differences between both groups which could impact one-year mortality [19]. Short-term outcomes have been previously pooled and reported in meta-analysis by others; thus our literature review was designated to evaluate one-year mortality [20].…”
Section: Methodsmentioning
confidence: 99%
“…Although it seems straightforward to proceed with transcatheter replacement for a TAS in nonsurgical candidates, it becomes challenging to choose TAVR in a similar patient with BAV especially with aortic root dilatation and demands experience, discussion, and consensus among various members of a multidisciplinary team. TAVR for BAV remains an off-label indication and carries a higher risk of paravalvular regurgitation [5]. Moreover, there is an additional risk of malpositioning, maldeployment, and malexpansion of the transcatheter AV prosthesis due to asymmetric, excessively calcified larger annulus of BAV [5].…”
Section: Discussionmentioning
confidence: 99%
“…TAVR for BAV remains an off-label indication and carries a higher risk of paravalvular regurgitation [5]. Moreover, there is an additional risk of malpositioning, maldeployment, and malexpansion of the transcatheter AV prosthesis due to asymmetric, excessively calcified larger annulus of BAV [5].…”
Section: Discussionmentioning
confidence: 99%